Topical treatment of psoriasis: A systematic update;Aktuelle aspekte der topischen psoriasisbehandlung

Hautarzt

Volumn 54, Issue 3, 2003, Pages 237-241

  Aschoff, R ^a   Wozel, G ^a   Meurer, M ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Calcipotriol; Combination regimens; Psoriasis; Topical treatment

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; CORTICOSTEROID; DITHRANOL; HYDROCORTISONE; HYDROXYCORTICOSTEROID; RETINOID DERIVATIVE; TACALCITOL; TAZAROTENE; VITAMIN D DERIVATIVE;

ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; EMBRYOTOXICITY; ERYTHEMA; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; MONOTHERAPY; PRURITUS; PSORIASIS; TERATOGENICITY; ULTRAVIOLET RADIATION;

EID: 0038200665     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-003-0498-1     Document Type: Article

References (40)

1. Braun-Falco O (1965) Zur Praxis der Psoriasis-Behandlung. Dtsch Med Wochenschr 90:1995-1998
2. Galewsky E (1916) Ober Cignolin, ein Ersatzpräparat des Chrysarobins. Derm Wochenschr 62:113-115
3. Scholz A, Kadner H (1991) 75 Jahre Cignolin. Hautarzt 42:775-778
4. Swanbeck G, Liden S (1966) The inhibitory effect of dithranol (anthralin) on DNA synthesis. Acta Derm Venereol 46:228-230
5. Gerritsen MJP (1999) Dithranol. In: van de Kerkhof PCM (ed) Textbook of psoriasis. Blackwell Science Ltd., London, pp 160-178
6. Kemeny L, Dobozy A (2001) Dithranol. In: Korting HC, Sterry W (Hrsg) Therapeutische Verfahren in der Dermatologie. Blackwell Wissenschafts-Verlag, Berlin Wien, S209-213
7. Comaish S (1965) Ingram method of treating psoriasis. Arch Dermatol 92:56-58
8. Pion IA, Koenig KL, Lim HW (1995) Is dermatologic usage of coal tar carcinogenic? A review of the literature. Dermatol Surg 21:227-231
9. Sulzberger MB, Witten VH (1952) The effect of topically applied compound F in selected dermatoses. J Invest Dermatol 19:101-102
10. Barnes PJ, Adcock I (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 15:138-139
11. Gollnick HPM, Bonnekoh B (1999) Topical and systemic retinoids. In: van de Kerkhof PCM (ed) Textbook of psoriasis. Blackwell Science Ltd., London, pp 233-256
12. Esgleyes-Ribot T, Chandraratna RA, Lew-Kaya DA, Sefton J, Duvic M (1994) Response of psoriasis to a new topical retinoid, AGN 190168. J Am Acad Dermatol 30:581-590
13. Gollnick H, Menter A (1999) Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis. Br J Dermatol 140 [Suppl 54]:18-23
14. Lowe NJ (1999) Optimizing therapy: tazarotene in combination with phototherapy. Br J Dermatol 140 [Suppl 54]:8-11
15. Zügel U, Steinmeyer A, Giesen C, Asadullah K (2002) A novel immunosuppressive 1α, 25-dihydroxyvitamin D3 analog with reduced hypercalcemic activity. J Invest Dermatol 119:1434-1442
16. Rigby WF, Waugh MG (1992) Decreased accessory cell function and costimulatory activity by 1,25-dihydroxy-vitamin D3-treated monocytes. Arthritis Rheum 35:110-119
17. Hosomi J, Hosoi J, Abe E et al. (1983) Regulation of terminal differentiation of cultured mouse epidermal cells by 1alpha,25-dihydroxyvitamin D3. Endocrinology 113:1950-1957
18. Binderup L, Kragballe K (1992) Origin of the use of calcipotriol in psoriasis treatment. Rev Contemporary Pharmacotherapy 23:401-409
19. Fogh K, Kragballe K (1999) Vitamin D3 Analogues. In: van de Kerkhof PCM (ed) Textbook of psoriasis. Blackwell Science Ltd., London, pp 121-147
20. Langner A, Ashton P, van de Kerkhof PCM, Verjans H (1996) A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis. Br J Dermatol 135:385-389
21. Van de Kerkhof PCM, Berth-Jones J, Griffiths CEM et al. (2002) Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis. Br J Dermatol 146:414-422
22. Kerscher M, Volkenandt M, Plewig G, Lehmann P (1993) Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB. Lancet 342:923
23. Molin L (1999) Topical calcipotriol combined with phototherapy for psoriasis. Dermatology 198:375-381
24. Lehmann B, Genehr T, Knuschke P et al. (2001) UVB-induced conversion of 7-dehydrochotesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol 117:1179-1185
25. Frappaz A, Thivolet J (1993) Calcipotriol in combination with PUVA: a randomized double blind placebo study in severe psoriasis. Eur J Dermatol 3:351-354
26. Speight EL, Farr PM (1994) Calcipotriol improves the response of psoriasis to PUVA. Br J Dermatol 130:79-82
27. Ortonne JP (1994) Psoriasis: new therapeutic modality by calcipotriol and betamethason dipropionate. Nouvelle Dermatologique 13:746-751
28. Wozel G (1994) Effektivität der Kombinationsbehandlung mit Calcipotriol und Fluocinolonacetonid im Psoriasis Plaque-Test. Akt Dermatol 20:155-158
29. Lebwohl M (1997) Topical application of calcipotriene and corticosteroids: combination regimes. J Am Acad Dermatol 37:S55-58
30. Ruzicka T, Lorenz B (1998) Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical theapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. Br J Dermatol 138:254-258
31. Kragballe K, Barnes L, Hamberg KJ et al. (1998) Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br J Dermatol 139:649-654
32. Douglas WS, Poulin Y, Decroix J et al. (2002) A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol 82:131-135
33. Kaufmann R, Bibby AJ, Bissonnette R et al. (2002) A new calcipotriol/betamethasone dipropionate formulation (Daivobet™) is an effective once-daily treatment for psoriasis vulgaris. Dermatology 205:389-393
34. Guenther L, Cambazard F, van de Kerkhof PCM et al. (2002) Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. Br J Dermatol 147:316-323
35. Katz HI (1997) Combined topical calcipotriene ointment 0,005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: Review of the literature and results of a survey sent to 100 dermatologists. J Am Acad Dermatol 37:562-568
36. Mrowietz U, Gräber M, Bräutigam M et al. (1998) The novel ascomycin derivative SDZ ASM 981 is effictive for psoriasis when used topically under occlusion. Br J Dermatol 139:992-996
37. Remitz A, Reitamo S, Erkko P, Granlund H, Lauerma AI (1999) Tacrolimus ointment improves psoriasis in a microplaque assay. Br J Dermatol 141:103-107
38. Yamamoto T, Nishoioka K (2000) Topical tactolimus is effective for facial lesions of psoriasis. Acta Derm Venereol 80:451
39. Zonneveld IM, Rubins A, Jablonska S et al. (1998) Topical tacrolimus is not effective in chronic plaque psoriasis. Arch Dermatol 134:1101-1102
40. Erdogan M, Wright JR, McAlister VC (2002) Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model. Br J Dermatol 146:964-967